Ebola Virus in West Africa: Waiting for the Owl of Minerva

The evolving Ebola epidemic in West Africa is unprecedented in its size and scope, requiring the rapid mobilization of resources. It is too early to determine all of the ethical challenges associated with the outbreak, but these should be monitored closely. Two issues that can be discussed are (1) t...

Descripción completa

Detalles Bibliográficos
Autor principal: Upshur, Ross E. G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Netherlands 2014
Materias:
Critical Perspectives
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088741/
https://www.ncbi.nlm.nih.gov/pubmed/25294651
http://dx.doi.org/10.1007/s11673-014-9580-x
_version_ 1783509602191540224
author Upshur, Ross E. G.
author_facet Upshur, Ross E. G.
author_sort Upshur, Ross E. G.
collection PubMed
description The evolving Ebola epidemic in West Africa is unprecedented in its size and scope, requiring the rapid mobilization of resources. It is too early to determine all of the ethical challenges associated with the outbreak, but these should be monitored closely. Two issues that can be discussed are (1) the decision to implement and evaluate unregistered agents to determine therapeutic or prophylactic safety and efficacy and (2) the justification behind this decision. In this paper, I argue that it is not compassionate use that justifies this decision and suggest three lines of reasoning to support the decision.
format Online
Article
Text
id pubmed-7088741
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher Springer Netherlands
record_format MEDLINE/PubMed
spelling pubmed-70887412020-03-23 Ebola Virus in West Africa: Waiting for the Owl of Minerva Upshur, Ross E. G. J Bioeth Inq Critical Perspectives The evolving Ebola epidemic in West Africa is unprecedented in its size and scope, requiring the rapid mobilization of resources. It is too early to determine all of the ethical challenges associated with the outbreak, but these should be monitored closely. Two issues that can be discussed are (1) the decision to implement and evaluate unregistered agents to determine therapeutic or prophylactic safety and efficacy and (2) the justification behind this decision. In this paper, I argue that it is not compassionate use that justifies this decision and suggest three lines of reasoning to support the decision. Springer Netherlands 2014-10-08 2014 /pmc/articles/PMC7088741/ /pubmed/25294651 http://dx.doi.org/10.1007/s11673-014-9580-x Text en © Journal of Bioethical Inquiry Pty Ltd 2014 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Critical Perspectives
Upshur, Ross E. G.
Ebola Virus in West Africa: Waiting for the Owl of Minerva
title Ebola Virus in West Africa: Waiting for the Owl of Minerva
title_full Ebola Virus in West Africa: Waiting for the Owl of Minerva
title_fullStr Ebola Virus in West Africa: Waiting for the Owl of Minerva
title_full_unstemmed Ebola Virus in West Africa: Waiting for the Owl of Minerva
title_short Ebola Virus in West Africa: Waiting for the Owl of Minerva
title_sort ebola virus in west africa: waiting for the owl of minerva
topic Critical Perspectives
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7088741/
https://www.ncbi.nlm.nih.gov/pubmed/25294651
http://dx.doi.org/10.1007/s11673-014-9580-x
work_keys_str_mv AT upshurrosseg ebolavirusinwestafricawaitingfortheowlofminerva

Ejemplares similares